Market Place
Sourcing Support
FDA approves record eight biosimilars in H1 2024; okays first interchangeable biosimilars for Eylea
Biologics, or complex drugs that are derived from living organisms, have revolutionized treatment of
Top Pharma Companies & Drugs in 2023: Merck’s Keytruda emerges as top-selling drug; Novo, Lilly sales skyrocket
The pharma industry clearly recalibrated itself in 2023, turning its focus away from Covid and onto
FDA reports 62.5% growth in new drug approvals in H1 2023; Health Canada sees drop
After a year when
drug approvals by the US Food and Drug Administration
(FDA) slipped to the lowes
Company Tracker: Pfizer turns to acquisitions as Covid products’ sales nosedive
Over the last five years, a
lot has changed for Pfizer Inc, one of the world’s leading pharma
Top 100 pharma & biotech deals in 2022
The pandemic years haven’t been great for dealmaking. Our analysis of top 10 biopharma M&A tra
Amgen ends Humira’s 20-year reign in US with Amjevita launch
This week, AbbVie’s Humira (adalimumab) saw its 20-year exclusive
run come to an end in the U
FDA’s list of off-patent drugs suggests higher approvals of first generics in 2022
We usher in 2023 with the key highlights of the US Food and Drug Administration’s December 202
Top Pharma Companies & Drugs in 2021: Covid vaccines, pills cause churn in list
Every year, the list of top pharmaceutical products and companies by sales sees some churn. But the
America’s drug price hike conundrum in backdrop of 2019 Medicare Part D data
Nearly every
year, drugmakers ring in the new year with drug price increases in the US. This
year
Top drugs and pharma companies by sales in 2020
Last
year, the pandemic impacted everyone’s life in one way or the other. It turned
the lime
